Project Title: Challenging African Swine Fever outbreaks with innovative VLP-based vaccines” (ASF-INNOVAC)

Funding:  EUROSTARS 2

Project Nr.:  E!114258

Period: 36 months  01.10.2020.-30.09.2023.

Project funding: EUR 210 000.00

Partners: HypoPet, The Institute of Virology and Immunology, BISC Global

Coordinator: Martin Bachmann (HypoPet)

BMC Principle Investigator:  Dr. biol. K.Tārs

Project description:

The overall aim of ASF-INNOVAC is to to develop a safe and efficacious vaccine for ASF through VLPs based on antigens predicted by smart algorithms, constitutes such an innovative approach.

Information published: 01.10.2020.